The EPS projection of Hologic, Inc. (NASDAQ:HOLX) for quarter ended 2016-09-30 is $0.5. Last week, the projection for EPS was $0.5 against target of $0.5, a month earlier. While 2-months ago, this projection was $0.5 versus forecast of $0.5a quarter months earlier, posting a deviation of 0%.
Hologic, Inc. (NASDAQ:HOLX) posted that 18 days earlier, the share price was revised 5 times on upside. In addition, negative revisions were 0.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 1. While in last 120 and 90 days, positive revisions were 4, and 4, correspondingly.
The per-share earnings downgrade for Hologic, Inc. (NASDAQ:HOLX) in the preceding 30 and 120 were 0 and 0. While in 60 and 90 days were 0, and 0, in that order.
Hologic, Inc. (NASDAQ:HOLX) EPS target was $0.5 for the quarter closed 2. It was based on 11 calls. As on 2016-04-27 the EPS was $0.47. The change was $0.01, posting a deviation of 2.17%. The price projections gave a standard deviation of 0.01.
Quarterly Sales Estimates
Hologic, Inc. (NASDAQ:HOLX) sales prediction for the fiscal 2017 stands at $763.995 and the median estimate is at $763.995. Almost 2 analysts gave sales target.
Among this, the highest sales estimate is $765.7 while the lowest target is $762.29 showing standard deviation of 2.411%.
As many as 2 analysts have positive sales targets revision while 2 reduced sales estimates, posting a deviation of 0%.
Last month, 2 experts have positive sales number revision. Also, 2 research groups lowered the sales projections, posting a deviation of -0.235%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast, posting a deviation of -0.692%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...